Published 2005 | Version v1.0.0
Journal Article Open

Treatment-Continuity of ADHD Compared Using Immediate-Release and Extended-Release MPH

Abstract

The continuity of methylphenidate (MPH) therapy for ADHD in young Medicaid beneficiaries (ages 6 to 17 years) treated with immediate-release (IR) or extended-release (ER) MPH formulations was compared in an analysis of statewide California Medicaid claims (2000-2003) conducted at Columbia University, New York; University of Pennsylvania, Philadelphia; and McNeil Pharmaceuticals, Fort Washington, PA.

Files

PNB-19-52.pdf

Files (1.4 MB)

Name Size Download all
md5:05cf9a84efe12595573c203feee29362
1.4 MB Preview Download

Additional details

Identifiers

Other
PNB-19-52

Dates

Created
2005
When the item was originally created.